![Gabriel Lopez-Berestein](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Gabriel Lopez-Berestein
Corporate Officer/Principal chez
Bio-Path, Inc.
Profil
Gabriel Lopez-Berestein is the founder of Interpath Pharmaceuticals, Inc. (founded in 2001), Bio-Path, Inc. (founded in 2007), and Bio-Path Holdings, Inc. (founded in 2007).
He also worked as a Director at Yellowstone Capital, Inc.
Postes actifs de Gabriel Lopez-Berestein
| Sociétés | Poste | Début |
|---|---|---|
Bio-Path, Inc.
 Bio-Path, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical drugs | Corporate Officer/Principal | 01/01/2007 |
Interpath Pharmaceuticals, Inc.
 Interpath Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops cancer therapeutics based on liposomal delivery technology for antisense | Corporate Officer/Principal | 01/01/2001 |
Anciens postes connus de Gabriel Lopez-Berestein
| Sociétés | Poste | Fin |
|---|---|---|
Yellowstone Capital Partners LLC
 Yellowstone Capital Partners LLC Investment ManagersFinance Yellowstone Capital invests in lower middle market companies located in the United States with a revenue of USD 10 - 50 million. The firm focuses on the branded food and beverages sector. It provides financing for growth, buyout, mezzanine, and MBOs. The firm acts as a lead investor and acquires majority and minority stakes. It also makes follow-on investments. | Directeur/Membre du Conseil | 29/02/2008 |
| BIO-PATH HOLDINGS, INC. | Fondateur | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
6
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Interpath Pharmaceuticals, Inc.
Interpath Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops cancer therapeutics based on liposomal delivery technology for antisense | Health Technology |
Bio-Path, Inc.
Bio-Path, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical drugs | Health Technology |
Bio-Path Holdings, Inc.
 Bio-Path Holdings, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company, which focuses on developing therapeutic products | Health Technology |
Yellowstone Capital Partners LLC
Yellowstone Capital Partners LLC Investment ManagersFinance Yellowstone Capital invests in lower middle market companies located in the United States with a revenue of USD 10 - 50 million. The firm focuses on the branded food and beverages sector. It provides financing for growth, buyout, mezzanine, and MBOs. The firm acts as a lead investor and acquires majority and minority stakes. It also makes follow-on investments. | Finance |
Choisissez Zonebourse 
